We create safe, effective and differentiated pharmaceutical solutions and this has been our goal since day 1. The main driver of our growth is innovation to improve the quality of peoples health under a sustainable business model.
- Learn all about Procaps Group participation at CPhI FRANKFURT 2022
- Discover the endless opportunities our Softgel Capsule can offer to your brand.
- Procaps Group Acquires 1st U.S.-Based Softgel Production Facility under the name Sofgen Pharmaceuticals, expanding its iCDMO Business Unit.
- Funtrition by Procaps expands its gummy offerings with new Gummy manufacturing facility in the US